Annals | Clinical | Eurofins-Viracor

2024 Year in Review: Reflecting on Progress and Innovation at Eurofins Viracor

Eurofins Viracor remains a leader in diagnostic testing for critical patients, leveraging over 40 years of expertise to provide accurate, reliable results with fast turnaround times. In 2024, the company launched several advanced assays, including the NeXGen™ Fungal/AFB NGS assay, the TTViWATCH Torque Teno Virus viral load monitoring assay, and the TA-TMA comprehensive assays. These innovations enhance diagnostic accuracy, support timely clinical decisions, and improve patient outcomes, particularly in complex and high-risk cases. Eurofins Viracor’s ongoing commitment to excellence and innovation ensures that healthcare professionals have access to the latest tools for informed therapeutic choices.

Streamline with LabAlert

Eurofins Viracor’s LabAlert app offers healthcare providers seamless, mobile access to patient test results, ensuring timely, informed decision-making. With 24/7 access, LabAlert enhances efficiency, allowing providers to make quicker, data-driven treatment decisions anytime and anywhere. LabAlert is an essential tool for those managing critically ill or immunocompromised patients.

The Critical Role of NTM and Fungal Testing during CAR T-Cell Therapy

In this post, we emphasize the critical need for nontuberculous mycobacteria (NTM) and fungal testing for patients undergoing CAR T-cell therapy. While this innovative treatment has shown effectiveness against certain cancers...

E-book & Resource Center

This interactive e-book presents a synopsis of our operations, services, and, most importantly, our commitment to you and your patients. Viracor delivers accurate results, exceptional turnaround times, and personalized guidance that empowers you to make informed healthcare decisions for your patients...

Clinical Application of Torque Teno Virus (TTV)

Torque Teno Virus (TTV) is a single-stranded circular DNA virus which has been identified as a surrogate marker of immune competence in transplantation. The monitoring of TTV loads can be a valuable tool in determining the risk of infection or rejection after a person undergoes a transplantation...

Exploring TTV (Torque Teno Virus) Testing: A Promising Tool for Managing Patient Health

Torque Teno Virus (TTV), a widely prevalent but often overlooked virus, is gaining attention in clinical diagnostics due to its potential role in immune system monitoring. Eurofins Viracor is advancing TTV research and diagnostics...

CMV: A Critical Concern for Transplant Recipients

Eurofins Viracor highlights the critical impact of cytomegalovirus (CMV) on organ transplant recipients, emphasizing its potential for severe complications such as organ rejection and infections. Despite advancements in antiviral therapies, CMV remains a significant threat to patient health and survival...

TA-TMA Testing: Faster Results and a Comprehensive Approach

Eurofins Viracor's TA-TMA (Transplant-associated thrombotic microangiopathy) testing stands out for its comprehensiveness, offering clinicians a complete assessment of complement pathway regulation and potential deregulation with validated assays for Eculizumab, CH50, and sC5b-9...

The Utility of Hybrid-Capture NGS for Detecting Fungal and Acid-Fast Bacteria in Human Specimens

Next Generation Sequencing (NGS) testing has gained significant importance in the medical clinical laboratory in the United States over the past decade. In recent years, the field of molecular diagnostics has witnessed significant advancements...

Eurofins Viracor: Year in Review

As 2023 draws to a close, Eurofins Viracor, a leading infectious disease testing laboratory, takes a moment to reflect on the significant milestones and advancements achieved throughout the year. With a commitment to delivering cutting-edge diagnostic solutions, Eurofins Viracor has continued to push the boundaries of infectious disease testing...